Thomas Raueiser

Boehringer Ingelheim GmbH engages in the provision of central management and other services for the group companies on behalf of C.H. Boehringer Sohn AG & Co. KG. The group specializes in the development, production, and distribution of pharmaceutical products. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany.

CEVEC Pharmaceuticals GmbH engages in the manufacture of biopharmaceuticals using a human cell-based expression system. It provides therapeutic proteins and monoclonal antibodies. The company was founded by Stefan Kochanek in 2004 and is headquartered in Cologne, Germany.

NRW.BANK operates as a state-owned development bank, assisting the German Federal State of North Rhine-Westphalia in its economic and social advancements. It offers interest-subsidized loans, subordinated loans, grants, financing, and advisory services. Its business activities are strictly limited to the Federal State of North Rhine-Westphalia. It serves small and medium-sized enterprises (SMEs)/start ups, municipalities and the social housing sectors. The company was founded on August 1, 2002 and is headquartered in Duesseldorf, Germany.

Scienion AG develops and provides DNA biochips and protein microarrays. It provides its customers in the pharmaceutical, biotech, diagnostic and reagent supply markets, as well as in academic research institutions with products, and services to facilitate confidence and efficiency in aspects of its applications. The company was founded by Holger Eickhoff in 2000 and is headquartered in Dortmund, Germany.

Peppermint Holding GmbH operates as a holding company with interests in textile industries. Its company portfolios include Zwickauer Kammgarn, Ertex Jacquard, and Color Textil. The company was founded by Ingeborg Neumann in 1997 and is headquartered in Berlin, Germany.

Innolume GmbH manufactures laser diodes. Its products include single mode and broad-are laser diodes, DFB and DBR lasers, superluminescent diodes, semiconductor optical amplifiers, tapered amplifiers, gain chips, laser diode driver, and optical isolators. The company was founded by Bernd Meyer in 2005 and is headquartered in Dortmund, Germany.

Investitionsbank des Landes Brandenburg operates as an investment and business development bank. The firm promotes public and private investment projects in business, infrastructure, and housing. It also engages in the financing of projects by municipalities, municipal special-purpose associations, municipal enterprises, as well as social, scientific, educational, and cultural institutions. The company was founded on March 31, 1992 and is headquartered in Potsdam, Germany.

Founded in 1966, BANK IM BISTUM ESSEN eG is a state chartered commercial bank. The company is based in Essen, Germany and operates as a subsidiary of Bundesverband der Deutschen Volksbanken & Raiffeisenbanken eV.

Creathor Venture Management GmbH is an independent private equity firm specialized in technology venture capital investing. Creathor was foundedi n 2003 and is headquartered in Bad Homburg near Frankfurt in central Germany. The management invests their own capital, and manages venture capital funds on behalf of institutions.

NATRIX Separations, Inc. manufactures and supplies single use and multi-cycle disposable chromatography products to the life science, food, beverage and water markets. Its technology consists of a polymeric hydrogel formed within a flexible porous support matrix. The firm offers NatriFlo HD-Q membrane absorbers for single-use flow-through polish applications and Natrix HD-C hydrogel membrane devices for bind-elute applications. The company was founded by Alicja Mika, Lisa Crossley, and Ronald F. Childs in 2004 and is headquartered in Burlington, Canada.

DIREVO Industrial Biotechnology GmbH provides bioengineering services for industrial, molecular biology, and reaction chemistry applications. It offers enzyme and strain engineering, application development, and process engineering services. The firm also offers research and development services for bio-fuel production. The company was founded in July 2008 and is headquartered in Cologne, Germany.

azeti GmbH provides hardware components and applications. It also provides research and development services. The company was founded by Dirk D. Sommerfeld in 2006 and is headquartered in Berlin, Germany.

Part of C.H. Boehringer Sohn AG & Co. KG, Boehringer Ingelheim Pharma GmbH & Co., KG is a company that operates research-based pharmaceutical companies and serves. Boehringer Ingelheim Pharma GmbH & Co., KG is based in Ingelheim, Germany. The German company was founded in 1885 by Albert Boehringer. The CEO is Hubertus von Baumbach.

Boehringer Ingelheim (BIVF) is the venture capital arm of Boehringer Ingelheim International GmbH, itself a subsidiary of C.H. Boehringer Sohn AG & Co. KG. The firm was founded in 2010 and is headquartered in Ingelheim, Germany. It also has two US offices located in Fremont, California, and Cambridge, Massachusetts.

Cryotherapeutics SA develops and markets a cryotherapy system, with focus on highlighting the safety and efficacy of cryoneergy in the cardiovascular system. The firm specializes in the design of a proprietary system to be used in the treatment of coronary artery diseases that cause heart attacks. Its focus areas encompass technology research, system development, and early-stage product commercialization. The company was founded by Randell L. Werneth, John Yianni and Maurice Buchbinder on September 8, 2009 and is headquartered in Cologne, Germany.

AYOXXA Biosystems GmbH operates as a biotechnology firm. Its lunaris technology is the optimal analysis platform for the pre-clinical and clinical development work. The firm offers In-situ encoded bead array, a multiplexed protein analysis platform that allows users to measure proteins and biomolecular analytes. The company was founded by Dieter Trau and Andreas Schmidt in 2010 and is headquartered in Cologne, Germany.

Rigontec GmbH provides RNA-based immunotherapeutics for the treatment of cancer and viral diseases. The firm develops a compound stimulating the immune receptor retinoic acid-inducible gene. The company was founded by Annegret de Baey-Diepolder, Gunther Hartmann, Anna Schwickart, Marcel Renn, Christine Schuberth-Wagner and Veit Hornung in 2014 and is headquartered in Munich, Germany.

eTheRNA immunotherapies NV develops novel immunotherapies to overcome cancers and infectious diseases. The company was founded by Carlo Heirman, Kris Thielemans and Sonja van Meirvenne in January 21, 2013 and is headquartered in Niel, Belgium.

Fasciotens GmbH engages in the development of external medical device that provides solution for the open abdomen or abdominal compartment syndrome. It offers fasciotens abdomen. The company was founded by Gereon Lill and Frank Beyer in 2016 and is headquartered in Essen, Germany.

Kapitalbeteiligungsgesellschaft für die mittelständische is a private company based in Neuss, Germany. Kapitalbeteiligungsgesellschaft für die mittelständische provides investment services. The German company was founded in 1975 and the CEOs are Christoph Büth and Manfred Thivessen.

Emergence Therapeutics AG is biopharmaceutical company. It develops novel antibody drug conjugate. The company was founded by Jack Elands and Xavier Preville and is headquartered in Duisburg, Germany.

Resolve BioSciences GmbH is a German company that applies molecular cartography to provide scientists with a high-resolution view of spatial biology. The company is based in Monheim am Rhein, Germany. The company's proprietary technology offers full spatial context at subcellular resolution, which helps scientists detect individual transcripts and rare signals to interpret fundamental biology. The company's technology is used in critical fields such as oncology, neuroscience, infectious disease, and agriculture. The company was founded by Jason T. Gammack, and John Stark has been the CEO of the company since 2023.

Westdeutsche Spielbanken GmbH & Co. KG operates casinos and provides gambling services. The company is based in Duisburg, Germany. The German company is ultimately controlled by the State of North Rhine-Westphalia. Georg Lucht has been the CEO of the company since 2019.